- ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Lamotrigine Dispersible Tablets BP 100 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Lamictal (Lamotrigine) Dispersible Tablets 100 mg, Manufactured by: Delpharm Poznaÿ – Poland & Registered and Imported by: GlaxoSmithKline Brasil Ltda, in healthy adult, human subjects under fasting condition.
This study compares two different versions of a medicine called lamotrigine, used for epilepsy and bipolar disorder. Researchers want to see if a new tablet works the same way as an existing one, by giving single doses to healthy adult volunteers.
Romania - ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and safety of memantine as antimanic and mood-stabilizing medication for adolescents with Bipolar Disorder: a monocentric, randomized, double-blind, placebo-controlled clinical trial.
This study is looking at a medicine called memantine to see if it can help teenagers with bipolar disorder. It's comparing memantine to a dummy pill (placebo) to check if it reduces manic symptoms and helps keep mood stable. The study will last for 52 weeks.
Italy - authorisedPhase III and phase IV (Integrated)
EFFECTIVENESS OF SUPPLEMENTATION WITH VITAMIN D IN PATIENTS WITH DEPRESSIVE DISORDER OR BIPOLAR DISORDER: A RANDOMIZED CONTROLLED CLINICAL TRIAL
This study is looking at whether taking vitamin D can help people with depression or bipolar disorder. Researchers want to see if it makes their symptoms better, using a common way to measure depression. They are comparing vitamin D to a dummy treatment.
Italy